Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol in Prodromal and Mild Dementia With Lewy Bodies
NCT04588285Phase 2Recruiting
- Sponsor
- Helse Fonna
- Start
- May 2021
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ambroxol hydrochloride oral solution in dementia with Lewy bodies (DLB), sponsored by Helse Fonna. Started May 2021; status: recruiting.
02
Drugs
Ambroxol hydrochloride oral solution
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NCT04588285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04588285.